Abstract
Pheochromocytoma (PCC) in children is rare, genetically not well described, and often related to a poor prognosis. We detected genomic imbalances in all 14 tumors from children analyzed by comparative genomic hybridization. A combinatorial loss of chromatin from 3p and 11p was a common feature in 10 of 14 (72%) patients, which was a result of either a loss of a total chromosome 3 and a total chromosome 11 in 6 of 10 patients, or confined deletions of their p arms in 4 of 10 patients. All patients exhibiting a loss of 3p and 11p carried VHL mutations. The VHL mutations were constitutive in 9 cases and somatic and restricted to tumor DNA in the remaining tumor. On the other hand, VHL mutations were absent in 4 patients, 2 who had other familial syndromes (NF1, SDHD) and 2 with unknown etiology. Our data show that the pattern of imbalances in the tumor DNA of PCC patients strongly correlated with an underlying familial VHL mutation. Furthermore, we show that true sporadic PCC is rare in childhood. Thus, children with PCC should be checked for a related predisposing gene. This would also identify familial syndrome patients requiring long-term monitoring for other syndrome-related malignancies.
References
Nov 1, 1977·Cancer·M M Melicow
Feb 1, 1989·Human Genetics·I HenryC Junien
Jan 1, 1986·Journal of Cellular Physiology. Supplement·A G Knudson
Oct 1, 1994·Cancer Genetics and Cytogenetics·H J DeckerJ Green
Nov 1, 1993·Human Molecular Genetics·M R SpeicherT Ried
Jul 1, 1993·Human Molecular Genetics·F M RichardsB Zbar
Jan 1, 1995·Methods in Enzymology·P LichterS Joos
Jul 1, 1996·Klinische Pädiatrie·T ParlowskyP Kaatsch
Jan 20, 2000·Journal of Neurocytology·R PfragnerB Niederle
Feb 10, 2000·The American Journal of Pathology·E EdströmC Larsson
Aug 10, 2000·The American Journal of Pathology·H DannenbergR R de Krijger
Feb 15, 2001·The Journal of Pediatrics·H MircescuC Deal
Aug 3, 2001·Journal of Medical Genetics·B U BenderH P Neumann
Nov 6, 2001·Journal of Medical Genetics·M KirchhoffC Lundsteen
Feb 1, 2002·The Journal of Clinical Hypertension·William M Manger, Ray W Gifford
Feb 19, 2002·Oncogene·Weng Onn LuiBin Tean Teh
Feb 19, 2002·Oncogene·Alexander O VortmeyerZhengping Zhuang
Mar 14, 2002·Seminars in Nephrology·Hartmut P H NeumannOthon Iliopoulos
May 10, 2002·The New England Journal of Medicine·Hartmut P H NeumannUNKNOWN Freiburg-Warsaw-Columbus Pheochromocytoma Study Group
Jun 13, 2002·Nucleic Acids Research·Jan P SchoutenGerard Pals
Jul 13, 2002·Journal of Medical Genetics·C CybulskiJ Lubiński
Dec 6, 2002·The Journal of Clinical Endocrinology and Metabolism·Christian A KochGeorge P Chrousos
Dec 17, 2003·Frontiers of Hormone Research·O GimmH P Neumann
Apr 6, 2004·Oncogene·Erik F HensenCees J Cornelisse
Apr 7, 2004·Cancer Genetics and Cytogenetics·Kathrin RiemannNikolaus Blin
Aug 26, 2004·JAMA : the Journal of the American Medical Association·Hartmut P H NeumannUNKNOWN European-American Paraganglioma Study Group
Oct 12, 2004·Cancer Genetics and Cytogenetics·Bastian GunawanLászló Füzesi
Mar 25, 2005·Endocrine-related Cancer·C D E MargettsE R Maher
Oct 11, 2005·Genes, Chromosomes & Cancer·Marieke AartsRonald R de Krijger
Citations
Mar 6, 2008·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Matthew M Grinsell, Victoria F Norwood
Apr 5, 2011·Pathology Oncology Research : POR·Ales VichaMarie Jarosova
Sep 14, 2010·Best Practice & Research. Clinical Endocrinology & Metabolism·Marta Barontini, Patricia L M Dahia
Apr 18, 2015·International Journal of Endocrinology·Andrea LuchettiEamonn R Maher
Jan 15, 2009·The Journal of Pathology·Esther KorpershoekRonald R de Krijger
May 15, 2008·Pediatric Blood & Cancer·Ivan F LoncarevicPeter Bucsky
Mar 28, 2013·American Journal of Medical Genetics. Part a·Jennifer M KalishMatthew A Deardorff
Feb 17, 2019·International Journal of Molecular Sciences·Thomas Liehr